APOE and atherosclerosis: For example, LXR activation by agonists such as T0901317 not only inhibits the development of atherosclerosis in ApoE−/− mice but also induces regression of advanced lesions by enhancing macrophage cholesterol metabolism and promoting CCR7-dependent egress of monocyte-derived macrophages from aortic plaques.383